Bg pattern

CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Clopidogrel Teva 75 mg Film-Coated Tablets EFG

clopidogrel

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Clopidogrel Teva and what is it used for
  2. What you need to know before taking Clopidogrel Teva
  3. How to take Clopidogrel Teva
  4. Possible side effects
  5. Storage of Clopidogrel Teva
  6. Contents of the pack and further information

1. What is Clopidogrel Teva and what is it used for

Clopidogrel Teva contains clopidogrel and belongs to a group of medications called antiplatelet agents. Platelets are very small cells that are found in the blood, and they aggregate when the blood clots. Antiplatelet agents, by preventing this aggregation, reduce the likelihood of blood clots (a process called thrombosis) forming.

Clopidogrel Teva is administered to adults to prevent the formation of blood clots (thrombi) in blood vessels (arteries) that have become hardened, a process known as atherothrombosis, which can cause atherothrombotic events (such as stroke, myocardial infarction, or death).

You have been prescribed Clopidogrel Teva to help prevent the formation of blood clots and reduce the risk of these serious events, as:

  • You suffer from a process that causes hardening of the arteries (also known as atherothrombosis), and
  • You have previously suffered a myocardial infarction, a stroke, or suffer from a disease called peripheral arterial disease, or
  • You have suffered a type of severe chest pain, known as "unstable angina" or "myocardial infarction". For the treatment of this disease, your doctor may need to place a stent in the obstructed or narrowed artery to restore adequate blood flow. It is also possible that your doctor has prescribed acetylsalicylic acid (a substance present in many medications used to relieve pain and reduce fever, as well as to prevent blood clots).
  • you have experienced symptoms of a stroke that disappear within a short period (also known as a transient ischemic attack) or a mild ischemic stroke. Your doctor may also administer acetylsalicylic acid during the first 24 hours.
  • you have an irregular heartbeat, a disease called "atrial fibrillation", and you cannot take medications known as "oral anticoagulants" (vitamin K antagonists) that prevent the formation of new clots and prevent the growth of existing clots. You will have been told that "oral anticoagulants" are more effective than acetylsalicylic acid or the combined use of Clopidogrel Teva and acetylsalicylic acid for this disease. Your doctor will have prescribed Clopidogrel Teva plus acetylsalicylic acid if you cannot take "oral anticoagulants" and do not have a risk of severe bleeding.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Clopidogrel Teva

Do not take Clopidogrel Teva:

  • If you are allergic (hypersensitive) to clopidogrel or any of the other components of this medication (listed in section 6).
  • If you have an active bleeding disorder, such as a stomach ulcer or bleeding in the brain.
  • If you have a severe liver disease.

If you think any of these cases apply to you, or if you have any doubts, consult your doctor before taking Clopidogrel Teva.

Warnings and precautions

Before starting treatment with Clopidogrel Teva, inform your doctor if you are in any of the following situations:

  • If you have a risk of bleeding (bleeding) because:
    • you have a disease that involves a risk of internal bleeding (such as a stomach ulcer).
    • you have a blood disorder that predisposes you to internal bleeding (bleeding in tissues, organs, or joints of the body).
    • you have recently had a severe injury.
    • you have recently undergone surgery (including dental surgery).
    • you are scheduled to undergo surgery (including dental surgery) within the next seven days.
  • If you have had a blood clot in an artery of the brain (ischemic stroke) in the last 7 days.
  • If you have liver or kidney disease.
  • If you have had an allergy or reaction to any medication used to treat your disease.
  • If you have had a non-traumatic cerebral hemorrhage.

While you are being treated with Clopidogrel Teva:

  • Inform your doctor if you are going to undergo surgery (including dental surgery).
  • Also, inform your doctor immediately if you develop a condition (also known as Thrombotic Thrombocytopenic Purpura or TTP) that includes fever and bruising (bruises) under the skin that can appear as red spots, with or without unexplained extreme fatigue, confusion, yellow color of the skin or eyes (jaundice) (see section 4 "Possible side effects").
  • If you cut or injure yourself, the bleeding may take longer than usual to stop. This is related to the way the medication works, as it prevents the formation of blood clots. For small cuts and injuries, e.g., when shaving, this is not important. However, if you are concerned about the bleeding, consult your doctor immediately (see section 4 "Possible side effects").
  • Your doctor may ask you to have blood tests.

Children and adolescents

This medication should not be administered to children as it is not effective.

Taking Clopidogrel Teva with other medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including those obtained without a prescription.

Some of these medications may affect the use of Clopidogrel Teva or vice versa.

You must explicitly inform your doctor if you are taking:

  • medications that may increase the risk of bleeding, such as:
  • oral anticoagulants, medications used to decrease blood clotting,
  • non-steroidal anti-inflammatory drugs, medications used to treat pain and/or inflammation of muscles or joints,
  • heparin, or any other injectable medication used to decrease blood clotting,
  • ticlopidine, another antiplatelet agent,
  • a serotonin reuptake inhibitor (such as fluoxetine or fluvoxamine and other medications of the same type), medications used to treat depression,
  • rifampicin (used for severe infections)
  • omeprazole or esomeprazole, medications to treat stomach discomfort,
  • fluconazole or voriconazole, medications to treat fungal infections,
  • efavirenz, or other antiretroviral medications (used to treat HIV infections),
  • carbamazepine, a medication to treat some forms of epilepsy,
  • moclobemide, a medication for depression,
  • repaglinide, a medication for the treatment of diabetes,
  • paclitaxel, a medication for the treatment of cancer,
  • opioids: if you are being treated with clopidogrel, you should inform your doctor before being prescribed any opioid (used to treat severe pain),
  • rosuvastatin (used to reduce cholesterol levels).

If you have suffered severe chest pain (unstable angina or myocardial infarction), a transient ischemic attack, or a mild ischemic stroke, you may have been prescribed clopidogrel in combination with acetylsalicylic acid, a substance present in many medications used to relieve pain and reduce fever. A dose of acetylsalicylic acid administered occasionally (not exceeding 1,000 mg in 24 hours) should not cause any problems, but prolonged use in other circumstances should be discussed with your doctor.

Taking Clopidogrel Teva with food and drinks

Clopidogrel Teva can be taken with or without food.

Pregnancy and breastfeeding

It is preferable not to take this medication during pregnancy.

If you are pregnant or think you may be pregnant, inform your doctor or pharmacist before taking Clopidogrel Teva. If you become pregnant while taking Clopidogrel Teva, inform your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.

You should not breastfeed while taking this medication.

If you are breastfeeding or plan to breastfeed, inform your doctor before taking this medication.

Consult your doctor or pharmacist before using any medication.

Driving and using machines

It is unlikely that Clopidogrel Teva will affect your ability to drive or operate machines.

Clopidogrel Teva contains lactose.

If your doctor has told you that you have an intolerance to certain sugars (e.g., lactose), consult with them before taking this medication.

3. How to take Clopidogrel Teva

Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist again.

The recommended dose, even for patients with a disease called "atrial fibrillation" (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Teva per day, administered orally with or without food and at the same time each day.

If you have suffered severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe 300 mg or 600 mg of clopidogrel (1 or 2 tablets of 300 mg or 4 or 8 tablets of 75 mg) for you to take once at the start of treatment. Afterward, the recommended dose is one 75 mg tablet of Clopidogrel Teva per day, as described above.

If you have experienced symptoms of a stroke that disappear within a short period (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe 300 mg of Clopidogrel Teva (4 tablets of 75 mg) once at the start of treatment. Afterward, the recommended dose is one 75 mg tablet of Clopidogrel Teva per day, as described above, with acetylsalicylic acid for 3 weeks. Afterward, the doctor will prescribe either Clopidogrel Teva alone or acetylsalicylic acid alone.

You should take Clopidogrel Teva for as long as your doctor continues to prescribe it.

If you take more Clopidogrel Teva than you should

Contact your doctor or go to the emergency department of the nearest hospital, as there is an increased risk of bleeding.

If you forget to take Clopidogrel Teva

If you forget to take a dose of Clopidogrel Teva, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.

If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a missed tablet.

In the 28x1 tablet format, you can check the last day you took a Clopidogrel Teva tablet by looking at the calendar printed on the blister pack.

If you stop taking Clopidogrel Teva

Do not stop your treatment unless your doctor tells you to. Contact your doctor or pharmacist before stopping this medication.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can have side effects, although not everyone will experience them.

Contact your doctor immediately if you experience:

  • Fever or signs of infection or extreme fatigue. These symptoms may be due to a decrease in some blood cells.
  • Signs of liver problems, such as yellowing of the skin and/or the whites of the eyes (jaundice), associated or not with bleeding that appears under the skin in the form of red spots and/or confusion (see section 2 "Warnings and precautions").
  • Swelling of the mouth or skin disorders such as rashes, itching, and blisters on the skin.

These can be signs of an allergic reaction.

The most common side effect reported with Clopidogrel Teva is bleeding.

Bleeding can occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, or blood in the urine. In a small number of cases, bleeding in the eye, inside the head, abdomen, lungs, and joints.

If you experience prolonged bleeding while taking Clopidogrel Teva

If you cut or injure yourself, the bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medication, as it prevents the blood from forming clots. For minor cuts or injuries (such as when shaving), this is not important. However, if you have any doubts, the bleeding worsens, or you experience unexpected bleeding in unusual parts of your body, you should contact your doctor immediately (see section 2 "Warnings and precautions").

Other side effects include:

Common side effects (may affect up to 1 in 10 people):

Diarrhea, abdominal pain, indigestion, or stomach upset

Uncommon side effects (may affect up to 1 in 100 people)

Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling, and numbness.

Rare side effects (may affect up to 1 in 1,000 people):

Dizziness, breast enlargement in men.

Very rare side effects (may affect up to 1 in 10,000 people):

Jaundice; severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., feeling of heat with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin; skin allergy; inflammation of the mouth mucosa (stomatitis); decreased blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.

Side effects of unknown frequency (cannot be estimated from the available data): Hypersensitivity reactions with chest or abdominal pain.

In addition, your doctor may observe changes in the results of your blood or urine tests.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Clopidogrel Teva

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the packaging, bottle, or blister after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions. Do not use this medication if you observe any visible signs of deterioration.

Medications should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medications that are no longer needed. This will help protect the environment.

6. Packaging Contents and Additional Information

Clopidogrel Teva Composition:

  • The active ingredient is clopidogrel. Each film-coated tablet contains 75 mg of clopidogrel (as hydrogen sulfate).
  • The other ingredients are (see section 2 "Clopidogrel Teva contains lactose"):
    • Tablet core: lactose monohydrate, microcrystalline cellulose, hydroxypropylcellulose (E463), crospovidone (type A), hydrogenated vegetable oil, and sodium lauryl sulfate
    • Tablet coating: lactose monohydrate, hypromellose (E464), titanium dioxide (E171), macrogol 4000, red iron oxide (E172), yellow iron oxide (E172), aluminum indigo carmine lacquer (E132).

Product Appearance and Packaging Contents:

  • The film-coated tablets are light pink to pink, film-coated, capsule-shaped tablets. One side of the tablet is engraved with the number "93". The other side of the tablet is engraved with the number "7314".
  • Clopidogrel Teva is available in
    • Perforated aluminum/aluminum blisters with a peelable lid containing 14x1, 28x1, 30x1, 50x1, 84x1, 90x1, or 100x1 tablets;
    • Perforated aluminum/aluminum blisters containing 14x1, 28x1, 30x1, 50x1, 84x1, 90x1, or 100x1 tablets
    • HDPE bottles with a polypropylene cap or a safety cap and a desiccant silica gel containing 30 or 100 tablets. Only certain pack sizes may be marketed.
    • Calendar blisters aluminum/aluminum packaging containing 28 x 1 tablets

Only certain pack sizes may be marketed.

  • Please note that the instructions for removing the tablet from the peelable blister are found on the outside of the box of peelable blisters.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder: Teva B.V.

Swensweg 5

2031GA Haarlem

Netherlands

Manufacturer:

TEVA Pharmaceutical Works Private Limited Company

Pallagi út 13,

4042 Debrecen, Hungary

TEVA Pharmaceutical Works Private Limited Company

Táncsics Mihály út 82,

2100 Gödöllo,

Hungary

Merckle GmbH

Ludwig-Merckle-Straße 3

89143 Blaubeuren

Germany

Balkanpharma Dupnitsa AD

3 Samokovsko Shosse Str., Dupnitsa 2600,

Bulgaria

For any information about this medicinal product, please contact the local representative of the Marketing Authorization Holder.

Belgium

Teva Pharma Belgium N.V./S.A.

Tel: +32 3 820 73 73

Lithuania

UAB “Sicor Biotech”

Tel: +370 5 266 02 03

Bulgaria

???? ????? ????

Phone: +359 2 489 95 82

Luxembourg

ratiopharm GmbH

Germany

Tel: +49 731 402 02

Czech Republic

Teva Pharmaceuticals CR, s.r.o.

Tel: +420 251 007 111

Hungary

Teva Gyógyszergyár Zrt.

Tel: +36 1 288 64 00

Denmark

Teva Denmark A/S Tel: +45 44 98 55 11

Malta

Teva Pharmaceuticals Ireland

Ireland

Tel: +44 2075407117

Germany

TEVA GmbH

Tel: (49) 731 402 08

Netherlands

Teva Nederland B.V.

Tel: +31 (0) 800 0228400

Estonia

Teva Eesti esindus UAB Sicor Biotech

Estonian branch

Tel: +372 661 0801

Norway

Teva Norway AS

Tel: +(47) 66 77 55 90

Greece

Teva Ελλάς Α.Ε.

Tel: +30 210 72 79 099

Austria

ratiopharm Arzneimittel Vertriebs-GmbH

Tel: +43 1 97007 0

Spain

TEVA PHARMA, S.L.U

Tel: +(34) 91 387 32 80

Poland

Teva Pharmaceuticals Polska Sp. z o.o.

Tel: +(48) 22 345 93 00

France

Teva Santé

Tel: +(33) 1 55 91 78 00

Portugal

Teva Pharma - Produtos Farmacêuticos Lda

Tel: (351) 214 76 7550

Croatia

Pliva Hrvatska d.o.o.

Tel: +385 1 37 20 000

Romania

Teva Pharmaceuticals S.R.L

Tel: +4021 230 65 24

Ireland

Teva Pharmaceuticals Ireland

Tel: 44 2075407117

Slovenia

Pliva Ljubljana d.o.o.

Tel: +386 1 58 90 390

Icelandratiopharm Oy Finland

Phone: +(358) 20 180 5900.

Slovakia

Teva Pharmaceuticals Slovakia s.r.o.

Tel: +(421) 2 5726 7911

Italy

Teva Italia S.r.l.

Tel: +(39) 028917981

Finland

ratiopharm Oy

Phone/Tel: +385 20 180 5900

Cyprus

Teva Ελλάς Α.Ε. Greece

Tel: +30 210 72 79 099

Sweden

Teva Sweden AB

Tel: +(46) 42 12 11 00

Latvia

UAB Sicor Biotech filiale Latvia

Tel: +371 67 323 666

United Kingdom(Northern Ireland)

Teva Pharmaceuticals Ireland

Tel: +44 2075407117

This leaflet was approved in {Month/year}

Detailed information on this medicinal product is available on the European Medicines Agency web site: http://www.ema.europa.eu

Online doctors for CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS

Discuss questions about CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS?
CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS?
The active ingredient in CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS is clopidogrel. This information helps identify medicines with the same composition but different brand names.
How much does CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS is around 16.81 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS?
CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS is manufactured by Teva B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CLOPIDOGREL TEVA 75 mg FILM-COATED TABLETS?
Other medicines with the same active substance (clopidogrel) include AGRELAN 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALMUS 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALTER 75 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media